Hepatitis B Foundation hails decision by U.S. Public Health Service Corps to accept future applicants living with chronic hepatitis B infection and HIV <<Click here>>

Patient and Provider Opportunities

The Hepatitis B Foundation is pleased to share information about current and upcoming opportunities for people living with hepatitis B and\or D and their providers. These opportunities can be tools and resources, clinical trials, or other research opportunities to learn more from people who have hepatitis B or coinfection with delta. 

Place Ads 10 Place Ads 11 Place Ads 12 Place Ads 14 Place Ads 15

If you are living with hepatitis delta, are at least 18 years old, and live in the United States, Mongolia, Algeria, Morocco, or Argentina, you are invited to participate in a new research opportunity! IQVIA and the Hepatitis B Foundation want to better understand the experience of living with hepatitis delta, including signs, symptoms, and impacts, to ensure that the voices of those with lived experience are included in the development of clinical trials and clinical management. This study does NOT include any treatment and will simply involve a 60-minute phone interview. You will receive compensation for your time! Share your story today - email contact@global-patients.com.  

Liver Cancer Drug Survey 2

The Canadian Cancer Survivor Network has a survey about Durvalumab+Tremelimumab for unresectable hepatocellular carcinoma. If you have experience with this medication combination, your feedback would be much appreciated!

Take the survey here


U.S. researchers seeking people living with hepatitis B 

Researchers across the U.S. are recruiting people living with hepatitis B for a clinical trial of a potential new treatment, which is called Cemiplimab. Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the study is being led by a University of California at Los Angeles team and has sites in L.A., New York City, Atlanta and other locations. If you’re interested, you can find eligibility information on ClinicalTrials.gov, using the identifier (NCT number): NCT04046107. Enrollment must be done through a physician. 


Disclaimer – The opportunities listed on this page do not represent all available opportunities. The Hepatitis B Foundation receives funding to provide information about the specific opportunities listed on this page. The Hepatitis B Foundation follows IRB-approved protocols and our own Corporate Ethics Policy for all listings. If you are interested in having an opportunity listed on this page, please email info@hepb.org.